![]() |
|
|
Vol. 16, Issue 1, 73-83, January 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dipartimento di Scienze Biochimiche, Università di Firenze, 50134 Firenze, Italy
Submitted January 8, 2004;
Revised October 12, 2004;
Accepted October 26, 2004
Monitoring Editor: Carl-Henrik Heldin
Cellular behavior can be considered to be the result of a very complex spatial and temporal integration of intracellular and extracellular signals. These signals arise from serum-soluble factors as well as from cellsubstrate or cellcell interactions. The current approach in mitogenesis studies is generally to analyze the effect of a single growth factor on serum-starved cells. In this context, a metabolic hormone such as insulin is found to be a mitogenic agent in many cellular types. In the present study, we have considered the effect of insulin stimulation in platelet-derived growth factor (PDGF)-activated NIH-3T3 and C2C12 cells. Our results show that insulin is able to inhibit strongly both NIH-3T3 and C2C12 cell growth induced by PDGF, one of the most powerful mitotic agents for these cell types. This inhibitory effect of insulin is due primarily to a premature down-regulation of the PDGF receptor. Thus, when NIH-3T3 or C2C12 cells are stimulated with both PDGF and insulin, we observe a decrease in PDGF receptor phosphorylation with respect to cells treated with PDGF alone. In particular, we find that costimulation with insulin leads to a reduced production of H2O2 with respect to cell stimulation with PDGF alone. The relative low concentration of H2O2 in PDGF/insulin-costimulated cell leads to a limited down-regulation of protein tyrosine phosphatases, and, consequently, to a reduced PDGF receptor phosphorylation efficiency. The latter is very likely to be responsible for the insulin-dependent inhibition of PDGF-receptor mitogenic signaling.
Abbreviations used: ERK, extracellular signal-regulated kinase; IR, insulin receptor; PDGF, platelet-derived growth factor, PDGF-R, platelet-derived growth factor-receptor; PI-3K, phosphatidylinositol 3-phosphate kinase; PTB, protein tyrosine-binding; PTK, protein tyrosine kinase; PTP, protein tyrosine phosphatase; ROS, reactive oxygen species; SH2, Src homology-2.
* Corresponding author. E-mail address: ramponi{at}scibio.unifi.it.
This article has been cited by other articles:
![]() |
V. Muralidharan-Chari, H. Hoover, J. Clancy, J. Schweitzer, M. A. Suckow, V. Schroeder, F. J. Castellino, J. S. Schorey, and C. D'Souza-Schorey ADP-Ribosylation Factor 6 Regulates Tumorigenic and Invasive Properties In vivo Cancer Res., March 15, 2009; 69(6): 2201 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhuang, Q. Pu, B. Ceacareanu, Y. Chang, M. Dixit, and A. Hassid Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H163 - H173. [Abstract] [Full Text] [PDF] |
||||